Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Nov 2021. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4668420010 | Product containing precisely levamisole hydrochloride 15 milligram/1 milliliter and mebendazole 10 milligram/1 milliliter conventional release oral suspension (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
4668421014 | Levamisole hydrochloride 15 mg/mL and mebendazole 10 mg/mL oral suspension | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely levamisole hydrochloride 15 milligram/1 milliliter and mebendazole 10 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has manufactured dose form | Oral suspension | true | Inferred relationship | Some | ||
Product containing precisely levamisole hydrochloride 15 milligram/1 milliliter and mebendazole 10 milligram/1 milliliter conventional release oral suspension (clinical drug) | Plays role | Anthelmintic therapeutic role | false | Inferred relationship | Some | ||
Product containing precisely levamisole hydrochloride 15 milligram/1 milliliter and mebendazole 10 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has precise active ingredient | Mebendazole (substance) | true | Inferred relationship | Some | 1 | |
Product containing precisely levamisole hydrochloride 15 milligram/1 milliliter and mebendazole 10 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has basis of strength substance (attribute) | Mebendazole (substance) | true | Inferred relationship | Some | 1 | |
Product containing precisely levamisole hydrochloride 15 milligram/1 milliliter and mebendazole 10 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Product containing precisely levamisole hydrochloride 15 milligram/1 milliliter and mebendazole 10 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 1 | |
Product containing precisely levamisole hydrochloride 15 milligram/1 milliliter and mebendazole 10 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has precise active ingredient | Levamisole hydrochloride | true | Inferred relationship | Some | 2 | |
Product containing precisely levamisole hydrochloride 15 milligram/1 milliliter and mebendazole 10 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has basis of strength substance (attribute) | Levamisole hydrochloride | true | Inferred relationship | Some | 2 | |
Product containing precisely levamisole hydrochloride 15 milligram/1 milliliter and mebendazole 10 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Product containing precisely levamisole hydrochloride 15 milligram/1 milliliter and mebendazole 10 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 2 | |
Product containing precisely levamisole hydrochloride 15 milligram/1 milliliter and mebendazole 10 milligram/1 milliliter conventional release oral suspension (clinical drug) | Is a | Product containing only levamisole and mebendazole in oral dose form (medicinal product form) | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets